Gianluca Gaïdano

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Jan A. Burger, Alessandra Tedeschi, Paul M. Barr et al. · New England Journal of Medicine · 2015 · 1.5K citations · Full text

Analysis of the coding genome of diffuse large B-cell lymphoma

Laura Pasqualucci, Giulia Fabbri, Jing Ma et al. · Nature Genetics · 2011 · 957 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Next-generation Sequencing +7

Inactivating mutations of acetyltransferase genes in B-cell lymphoma

Laura Pasqualucci, David Dominguez-Sola, Annalisa Chiarenza et al. · Nature · 2011 · 919 citations · Full text

B-cell Lymphoma, Lymphoid Neoplasia, Pathology +4

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

Gianluca Gaïdano, Paola Ballerini, Jerry Z. Gong et al. · Proceedings of the National Academy of Sciences · 1991 · 896 citations · Full text

Chronic Lymphocytic Leukemia, Mixed-phenotype Acute Leukemia, Immunology +17

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

Meletios Α. Dimopoulos, Philippe Moreau, Antonio Palumbo et al. · The Lancet Oncology · 2015 · 834 citations · Full text

Hematological Malignancy, Oncology, Dexamethasone Versus Bortezomib +8